Lattice Biologics Ltd. (LBLTF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | - USD | 0.0% |
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 1.28 Million USD | -15.92% |
| 2019 | 1.52 Million USD | -24.53% |
| 2018 | 2.02 Million USD | -34.44% |
| 2017 | 3.08 Million USD | -27.6% |
| 2016 | 4.26 Million USD | 102828.63% |
| 2015 | 4145.22 USD | -97.49% |
| 2014 | 165.1 Thousand USD | -17.63% |
| 2013 | 200.44 Thousand USD | -18.23% |
| 2012 | 245.11 Thousand USD | -42.8% |
| 2011 | 428.51 Thousand USD | -49.96% |
| 2010 | 856.42 Thousand USD | -39.98% |
| 2009 | 1.42 Million USD | -43.03% |
| 2008 | 2.5 Million USD | -6.66% |
| 2007 | 2.68 Million USD | 95.15% |
| 2006 | 1.37 Million USD | 43.86% |
| 2005 | 955.85 Thousand USD | 45.53% |
| 2004 | 656.82 Thousand USD | 0.0% |
| 2002 | 80.57 Thousand USD | -30.77% |
| 2001 | 116.4 Thousand USD | 18.65% |
| 2000 | 98.1 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q2 | - USD | 0.0% |
| 2023 FY | - USD | 0.0% |
| 2023 Q4 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2021 Q3 | 25.84 Thousand USD | -93.43% |
| 2021 Q1 | 345.33 Thousand USD | 53.89% |
| 2021 Q2 | 393.2 Thousand USD | 13.86% |
| 2021 FY | - USD | -100.0% |
| 2020 Q4 | 224.39 Thousand USD | -39.98% |
| 2020 Q1 | 352.8 Thousand USD | -19.32% |
| 2020 Q2 | 333.88 Thousand USD | -5.36% |
| 2020 Q3 | 373.88 Thousand USD | 11.98% |
| 2020 FY | 1.28 Million USD | -15.92% |
| 2019 Q2 | 389 Thousand USD | 18.59% |
| 2019 FY | 1.52 Million USD | -24.53% |
| 2019 Q1 | 328.01 Thousand USD | -52.03% |
| 2019 Q3 | 373.99 Thousand USD | -3.86% |
| 2019 Q4 | 437.31 Thousand USD | 16.93% |
| 2018 FY | 2.02 Million USD | -34.44% |
| 2018 Q4 | 683.72 Thousand USD | 33.98% |
| 2018 Q3 | 510.32 Thousand USD | 22.54% |
| 2018 Q2 | 416.44 Thousand USD | 0.44% |
| 2018 Q1 | 414.62 Thousand USD | -17.42% |
| 2017 Q2 | 988.44 Thousand USD | 3.52% |
| 2017 Q1 | 954.84 Thousand USD | 15.42% |
| 2017 FY | 3.08 Million USD | -27.6% |
| 2017 Q4 | 502.11 Thousand USD | -21.98% |
| 2017 Q3 | 643.6 Thousand USD | -34.89% |
| 2016 Q1 | 1.06 Million USD | 975.85% |
| 2016 Q4 | 827.27 Thousand USD | -26.98% |
| 2016 FY | 4.26 Million USD | 102828.63% |
| 2016 Q3 | 1.13 Million USD | -8.38% |
| 2016 Q2 | 1.23 Million USD | 15.56% |
| 2015 Q4 | 99.45 Thousand USD | 314.89% |
| 2015 Q1 | 60.37 Thousand USD | 79.91% |
| 2015 Q3 | 23.97 Thousand USD | -33.63% |
| 2015 FY | 4145.22 USD | -97.49% |
| 2015 Q2 | 36.11 Thousand USD | -40.18% |
| 2014 Q3 | 31.38 Thousand USD | -24.52% |
| 2014 FY | 165.1 Thousand USD | -17.63% |
| 2014 Q1 | 68 Thousand USD | 66.69% |
| 2014 Q2 | 41.57 Thousand USD | -38.86% |
| 2014 Q4 | 33.55 Thousand USD | 6.94% |
| 2013 Q3 | 53.08 Thousand USD | 39.64% |
| 2013 Q2 | 38.01 Thousand USD | 483.98% |
| 2013 Q4 | 40.79 Thousand USD | -23.15% |
| 2013 Q1 | 6510.21 USD | -90.84% |
| 2013 FY | 200.44 Thousand USD | -18.23% |
| 2012 FY | 245.11 Thousand USD | -42.8% |
| 2012 Q4 | 71.03 Thousand USD | -24.26% |
| 2012 Q3 | 93.79 Thousand USD | 34.57% |
| 2012 Q2 | 69.69 Thousand USD | -51.99% |
| 2012 Q1 | 145.18 Thousand USD | 145.05% |
| 2011 Q1 | 253.63 Thousand USD | 13.82% |
| 2011 Q2 | 144.96 Thousand USD | -42.84% |
| 2011 FY | 428.51 Thousand USD | -49.96% |
| 2011 Q4 | 59.24 Thousand USD | -37.37% |
| 2011 Q3 | 94.6 Thousand USD | -34.74% |
| 2010 Q4 | 222.84 Thousand USD | 64.57% |
| 2010 FY | 856.42 Thousand USD | -39.98% |
| 2010 Q2 | 244.54 Thousand USD | 10.04% |
| 2010 Q3 | 135.41 Thousand USD | -44.63% |
| 2010 Q1 | 222.23 Thousand USD | -49.82% |
| 2009 FY | 1.42 Million USD | -43.03% |
| 2009 Q1 | 157.49 Thousand USD | -82.38% |
| 2009 Q2 | 432.92 Thousand USD | 174.88% |
| 2009 Q3 | 244.76 Thousand USD | -43.46% |
| 2009 Q4 | 442.9 Thousand USD | 80.95% |
| 2008 FY | 2.5 Million USD | -6.66% |
| 2008 Q4 | 893.67 Thousand USD | 16.59% |
| 2008 Q1 | 658.22 Thousand USD | -11.86% |
| 2008 Q3 | 766.53 Thousand USD | 4.02% |
| 2008 Q2 | 736.88 Thousand USD | 11.95% |
| 2007 Q1 | 582.64 Thousand USD | 207.91% |
| 2007 FY | 2.68 Million USD | 95.15% |
| 2007 Q3 | 475.94 Thousand USD | -28.55% |
| 2007 Q4 | 746.77 Thousand USD | 56.9% |
| 2007 Q2 | 666.08 Thousand USD | 14.32% |
| 2006 FY | 1.37 Million USD | 43.86% |
| 2006 Q1 | 481.56 Thousand USD | 257.54% |
| 2006 Q2 | 275.01 Thousand USD | -42.89% |
| 2006 Q3 | 316.75 Thousand USD | 15.17% |
| 2006 Q4 | 189.22 Thousand USD | -40.26% |
| 2005 FY | 955.85 Thousand USD | 45.53% |
| 2005 Q2 | 240.41 Thousand USD | 7.1% |
| 2005 Q3 | 79.8 Thousand USD | -66.81% |
| 2005 Q4 | 134.68 Thousand USD | 68.77% |
| 2005 Q1 | 224.48 Thousand USD | 79.7% |
| 2004 Q3 | 215.4 Thousand USD | 180.94% |
| 2004 Q2 | 76.67 Thousand USD | -3.35% |
| 2004 Q1 | 79.33 Thousand USD | 40.07% |
| 2004 Q4 | 124.92 Thousand USD | -42.01% |
| 2004 FY | 656.82 Thousand USD | 0.0% |
| 2003 Q1 | 11.83 Thousand USD | -55.43% |
| 2003 Q4 | 56.63 Thousand USD | 104.54% |
| 2003 Q2 | 22.37 Thousand USD | 89.02% |
| 2003 Q3 | 27.68 Thousand USD | 23.78% |
| 2002 Q3 | 20.34 Thousand USD | -57.78% |
| 2002 Q4 | 26.55 Thousand USD | 30.5% |
| 2002 Q1 | 20.7 Thousand USD | -23.63% |
| 2002 Q2 | 48.19 Thousand USD | 132.79% |
| 2002 FY | 80.57 Thousand USD | -30.77% |
| 2001 FY | 116.4 Thousand USD | 18.65% |
| 2001 Q3 | 21.71 Thousand USD | 0.0% |
| 2001 Q4 | 27.11 Thousand USD | 24.83% |
| 2000 FY | 98.1 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| CVR Medical Corp. | - USD | NaN% |
| BioElectronics Corporation | 740.67 Thousand USD | 100.0% |
| IR-Med Inc. | 4.89 Million USD | 100.0% |
| Polarean Imaging plc | 12.24 Million USD | 100.0% |
| Medical Supply International USA, Inc. | 1.32 Million USD | 100.0% |
| Avitar, Inc. | 3.56 Million USD | 100.0% |
| AVITA Medical, Inc. | 80.77 Million USD | 100.0% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | 100.0% |
| Össur hf. | 396.18 Million USD | 100.0% |
| Zecotek Photonics Inc. | 3.46 Million USD | 100.0% |
| QHSLab, Inc. | 961.65 Thousand USD | 100.0% |
| Wellstar International, Inc. | 1.79 Million USD | 100.0% |
| Össur hf. | 396.18 Million USD | 100.0% |
| Bionovate Technologies Corp | - USD | NaN% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 100.0% |
| Escalon Medical Corp. | 5.25 Million USD | 100.0% |
| Aurora Spine Corporation | 8.65 Million USD | 100.0% |
| BrainsWay Ltd. | 28.01 Million USD | 100.0% |
| NewCardio, Inc. | 9.56 Million USD | 100.0% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 100.0% |
| Vivos Inc. | 2.78 Million USD | 100.0% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 100.0% |
| Kelyniam Global, Inc. | 2.27 Million USD | 100.0% |
| REMSleep Holdings, Inc. | 1.01 Million USD | 100.0% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | 100.0% |
| Nanomix Corporation | 8.36 Million USD | 100.0% |
| Theraclion SA | 7.43 Million USD | 100.0% |
| Lifeline Biotechnologies, Inc. | - USD | NaN% |
| Wellness Center USA, Inc. | 1.29 Million USD | 100.0% |
| Positron Corporation | 1 Million USD | 100.0% |
| Rafina Innovations Inc. | - USD | NaN% |
| Electromedical Technologies, Inc. | 3.11 Million USD | 100.0% |
| Lombard Medical, Inc. | 30.29 Million USD | 100.0% |
| ALR Technologies Inc. | 6.33 Million USD | 100.0% |
| Stratec SE | 46.32 Million USD | 100.0% |
| Vycor Medical, Inc. | 1.27 Million USD | 100.0% |
| Heart Tronics, Inc. | 14.46 Million USD | 100.0% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | 100.0% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | 100.0% |
| SANUWAVE Health, Inc. | 14.15 Million USD | 100.0% |
| VMS Rehab Systems, Inc. | 63.63 USD | 100.0% |
| Guided Therapeutics, Inc. | 3.49 Million USD | 100.0% |
| Ingen Technologies, Inc. | 1.88 Million USD | 100.0% |
| Odyssey Group International, Inc. | -14.26 Million USD | 100.0% |
| United American Healthcare Corporation | 59 Thousand USD | 100.0% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | 100.0% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | 100.0% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | 100.0% |
| Urologix, Inc. | 10.09 Million USD | 100.0% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | 100.0% |
| Nexeon MedSystems Inc. | 5.94 Million USD | 100.0% |
| SS Innovations International, Inc. | 21.38 Million USD | 100.0% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | 100.0% |
| Smith & Nephew plc | 3.46 Billion USD | 100.0% |
| NIOX Group Plc | 22.27 Million USD | 100.0% |
| Fuse Medical, Inc. | 10.35 Million USD | 100.0% |
| Broncus Holding Corporation | 38.15 Million USD | 100.0% |
| Brain Scientific Inc. | 9.66 Million USD | 100.0% |
| Pressure BioSciences, Inc. | 10.3 Million USD | 100.0% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | 100.0% |